Zhejiang Orient Gene Biotech Co.,Ltd  specializes in the research, development, production and sales of in vitro diagnostic products. Through continuous endogenous R&D and outward investment, especially through the introduction of a Canadian research team specializing in antigen antibody R&D in 2016, the company has completed the layout of the whole industrial chain from biological raw materials such as antigen antibody, to in vitro diagnostic reagents and instruments, to third-party testing services, forming a business pattern with POCT rapid diagnostic reagents as the leading product, focusing on the development of molecular diagnostics, biological raw materials, diagnostic instruments and liquid biochips. The company's products are mainly used in drugs of abuse, infectious disease, fertility, tumor marker and cardiac marker.

In addition to POCT instant diagnostic reagent, according to the R&D field and direction, the company continues to invest in the R&D of biological raw material platform, molecular diagnostic platform, liquid biochip platform and in vitro diagnostic instrument platform, and formulates the strategy of synchronous development of each technology platform, so as to promote the development of the company through integrated R&D mode.